New York Blood Center (NYBC) welcomes Colleen Delaney, MD, MSc, as keynote speaker at the 36th Annual Alexander S. Wiener Lecture on May 6th in New York City at 4PM. Dr. Delaney will present ‘Ex Vivo Manipulation of Cord Blood Derived Hematopoietic Stem and Progenitor Cells for Clinical Application.’
Delaney’s research interests focus on the ex vivo expansion of hematopoietic stem and progenitor cells for clinical application. Specifically, she has focused on the role of the Notch signaling pathway in hematopoietic stem cell regulation and ex-vivo expansion of umbilical cord blood stem cells, resulting in the development of novel expanded hematopoietic progenitor cell therapies for use to enhance engraftment following myeloablative cord blood transplant.
Dr. Delaney is an Associate Member of the Fred Hutchinson Cancer Research Center (FHCRC) Clinical Research Division and an Associate Professor at the University of Washington in the Department of Pediatrics, Division of Pediatric Hematology/Oncology. She is also the recipient of the Madeline Dabney Adams Endowed Chair. In addition, she established and is the Director of the Program in Cord Blood Transplant and Research at the FHCRC/SCCA and is an attending physician at Seattle Children’s Hospital and the Seattle Cancer Care Alliance (SCCA).
In 2007 and 2010, Dr. Delaney was awarded a prestigious Damon Runyon Clinical Investigator Award. She was recognized as one of “Tomorrow’s PI” receiving a Young Investigator of the Year Award from Genome Technology Magazine (2007/2008) and a Seattle Top Doc in 2012 and 2013. Dr. Delaney also received a “Best Clinical Abstract Award” from the American Society of Bone Marrow Transplant in 2012 for her work on the use of cryopreserved expanded cord blood progenitors in the cord blood transplant setting.
NYBC’s Annual Alexander S. Wiener Lecture honors Dr. Alexander Solomon Wiener (1907-1976) who was internationally recognized for his significant contributions in the fields of forensic medicine, serology, and immunogenetics. His pioneering work led to discovery of the Rh factor in 1937, along with Dr. Karl Landsteiner, as well as the development of exchange transfusion methods that saved the lives of countless infants with hemolytic disease of the newborn.
This event, to be held in NYBC’s auditorium, is open to medical and scientific professionals, free of charge.
Register online at: https://support.nybloodcenter.org/wiener
About New York Blood Center: New York Blood Center (NYBC) is one of the nation's largest non-profit, community-based blood centers. For 50 years, NYBC has been providing blood, transfusion products and services to hospitals serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania. NYBC is also home to the Lindsley F. Kimball Research Institute and the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world's largest public cord blood bank. NYBC provides medical services and programs (Clinical, Transfusion, and Hemophilia Services) through our medical professionals along with consultative services in transfusion medicine. Please visit us on Facebook at www.Facebook.com/newyorkbloodcenter. Follow us on Twitter: @NYBloodCenter. Website: www.nybloodcenter.org